DK0797660T3 - Human-immunodefekt-virus-vacciner og terapeutiske midler indeholdende replikations-svækkede HIV-1 NEF deletions-mutanter - Google Patents

Human-immunodefekt-virus-vacciner og terapeutiske midler indeholdende replikations-svækkede HIV-1 NEF deletions-mutanter

Info

Publication number
DK0797660T3
DK0797660T3 DK95944422T DK95944422T DK0797660T3 DK 0797660 T3 DK0797660 T3 DK 0797660T3 DK 95944422 T DK95944422 T DK 95944422T DK 95944422 T DK95944422 T DK 95944422T DK 0797660 T3 DK0797660 T3 DK 0797660T3
Authority
DK
Denmark
Prior art keywords
hiv
nef
viral
gene product
immunodeficiency virus
Prior art date
Application number
DK95944422T
Other languages
English (en)
Inventor
Sateesh N Apte
Original Assignee
Sateesh N Apte
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sateesh N Apte filed Critical Sateesh N Apte
Application granted granted Critical
Publication of DK0797660T3 publication Critical patent/DK0797660T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16061—Methods of inactivation or attenuation
    • C12N2740/16062—Methods of inactivation or attenuation by genetic engineering
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16311—Human Immunodeficiency Virus, HIV concerning HIV regulatory proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DK95944422T 1994-12-27 1995-12-26 Human-immunodefekt-virus-vacciner og terapeutiske midler indeholdende replikations-svækkede HIV-1 NEF deletions-mutanter DK0797660T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36460094A 1994-12-27 1994-12-27
PCT/US1995/017002 WO1996020273A1 (en) 1994-12-27 1995-12-26 Human immunodeficiency virus vaccines and therapeutics containing replication-impaired hiv-1 nef-deletion mutants

Publications (1)

Publication Number Publication Date
DK0797660T3 true DK0797660T3 (da) 2008-12-15

Family

ID=23435246

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95944422T DK0797660T3 (da) 1994-12-27 1995-12-26 Human-immunodefekt-virus-vacciner og terapeutiske midler indeholdende replikations-svækkede HIV-1 NEF deletions-mutanter

Country Status (12)

Country Link
US (1) US6713064B1 (da)
EP (1) EP0797660B1 (da)
JP (1) JP4587496B2 (da)
AT (1) ATE405635T1 (da)
AU (1) AU718143B2 (da)
BR (1) BR9510473A (da)
CA (1) CA2209135C (da)
DE (1) DE69535817D1 (da)
DK (1) DK0797660T3 (da)
ES (1) ES2313723T3 (da)
PT (1) PT797660E (da)
WO (1) WO1996020273A1 (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL112636A0 (en) * 1994-02-14 1995-05-26 Macfarlane Burnet Ctre Med Res Non-pathogenic strains of hiv-1
US8124102B2 (en) * 1994-12-27 2012-02-28 Sateesh Apte Method for the reduction of viral loads in patients comprising the administration of nef-deficient human immunodeficiency virus (HIV)
WO2024048793A1 (ja) * 2022-09-02 2024-03-07 国立研究開発法人医薬基盤・健康・栄養研究所 感染を治療するための弱毒化ウイルス

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE147782T1 (de) * 1990-07-12 1997-02-15 Harvard College Primaten-lentivirus impfstoffe
US5851813A (en) * 1990-07-12 1998-12-22 President And Fellows Of Harvard College Primate lentivirus antigenic compositions
IL112636A0 (en) * 1994-02-14 1995-05-26 Macfarlane Burnet Ctre Med Res Non-pathogenic strains of hiv-1

Also Published As

Publication number Publication date
BR9510473A (pt) 1998-05-26
DE69535817D1 (de) 2008-10-02
ATE405635T1 (de) 2008-09-15
JP4587496B2 (ja) 2010-11-24
EP0797660B1 (en) 2008-08-20
WO1996020273A1 (en) 1996-07-04
AU4647496A (en) 1996-07-19
JPH10511400A (ja) 1998-11-04
PT797660E (pt) 2008-11-21
AU718143B2 (en) 2000-04-06
CA2209135C (en) 2008-07-08
CA2209135A1 (en) 1996-07-04
US6713064B1 (en) 2004-03-30
ES2313723T3 (es) 2009-03-01
EP0797660A4 (en) 1999-02-10
EP0797660A1 (en) 1997-10-01

Similar Documents

Publication Publication Date Title
Conant et al. Condoms prevent transmission of AIDS-associated retrovirus
Richman Zidovudine resistance of human immunodeficiency virus
Smith et al. Cutaneous neoplasms in a military population of HIV-1-positive patients
DE69632256D1 (de) Antivirale proteine, dafür kodierende dna, und deren verwendung
RU94002475A (ru) Фармацевтическая композиция и ее применение для лечения вирусных инфекций
EP2298350A3 (en) Composition comprising an inducing agent and an anti-viral agent for the treatment of viral disorders
Podzamczer et al. Low‐dose interferon alpha combined with zidovudine in patients with AIDS‐associated Kaposi's sarcoma
DK0797660T3 (da) Human-immunodefekt-virus-vacciner og terapeutiske midler indeholdende replikations-svækkede HIV-1 NEF deletions-mutanter
WO2003061602A3 (en) Combination therapy for treatment of hiv infection
Redfield et al. Female-to-male transmission of HTLV-III-reply
ES2310848T3 (es) Vacunas de virus enteros inactivados correspondientes a un subtipo para tratar pacientes con la infeccion vih.
Stephens et al. Significance of macrophage tropism of SIV in the macaque model of HIV disease
FR2694693B1 (fr) Composition pharmaceutique à base de flavopéréirine et son utilisation dans un traitement contre le virus VIH.
Carter et al. Mismatched double-stranded RNA, ampligen (poly (I): poly (C12U)), demonstrates antiviral and immunostimulatory activities in HIV disease
JPH069410A (ja) Ｈｉｖ感染の腸管外治療のための医薬
CA2350127A1 (en) Avipox vector coding an hiv antigen and a cytokine
Bernhard et al. Chronic ulcerating acyclovir-resistant varicella zoster lesions in an AIDS patient
Arvin et al. Alpha interferon administration to infants with congenital rubella
Levine Therapeutic approaches to neoplasms in AIDS
Marx The Slow, Insidious Natures of the HTLV's: The scope of the viruses that cause AIDS and certain leukemias and lymphomas is broadening in terms of number of people affected and range of clinical syndromes
De Wit AIDS‐associated Kaposi'i sarcoma and the mechanisms of interferon alpha'a activity; a riddle within a puzzle
Izu et al. GIANT MULLUSCUM CONTAGIOSUM PRESENTING AS A TUMOR IN AN HIV-INFECTED PATIENT.
Laurent-Crawford et al. Antiviral action of polyadenylic-polyuridylic acid against HIV in cell cultures
Goldberg et al. Bridging the gap: human diploid cell strains and the origin of AIDS
Bittencourt et al. Burkitt's lymphoma of the scapula